In conjunction with Institut Kanser Negara's (IKN) 10th anniversary, AstraZeneca announced its collaboration to accelerate digitalisation in healthcare by introducing Artificial Intelligence (AI) x-ray technology into early lung screening at government clinics and hospitals under the Projek Saringan Awal Paru-Paru (SAPU) programme. As a centre of excellence for cancer care in the country, IKN will be the first government institution in the country to implement this AI technology.
AstraZeneca to focus on rare diseases, continuing local investments thesundaily.my - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thesundaily.my Daily Mail and Mail on Sunday newspapers.
SINGAPORE, Dec 11 AstraZeneca’s Covid-19 antibody drug is expected to arrive in Singapore in the coming weeks, after the biopharmaceutical firm announced yesterday (December 10) that it had signed a new purchase agreement with the Singapore Government. The drug Evusheld combines two.